Characteristics of Dolutegravir and Bictegravir Plasma Protein Binding: a First Approach for the Study of Pharmacologic Sanctuaries
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Characteristics of Dolutegravir and Bictegravir Plasma Protein Binding: a First Approach for the Study of Pharmacologic Sanctuaries
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 64, Issue 11, Pages -
Publisher
American Society for Microbiology
Online
2020-08-31
DOI
10.1128/aac.00895-20
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dolutegravir Cerebrospinal Fluid Diffusion in HIV-1–Infected Patients with Central Nervous System Impairment
- (2019) Thibaut Gelé et al. Open Forum Infectious Diseases
- Total and Unbound Bictegravir Concentrations and Viral Suppression in Cerebrospinal Fluid of Human Immunodeficiency Virus-Infected Patients (Spanish HIV/AIDS Research Network, PreEC/RIS 56)
- (2019) Juan Tiraboschi et al. JOURNAL OF INFECTIOUS DISEASES
- UPLC–MS/MS method for the simultaneous quantification of bictegravir and 13 others antiretroviral drugs plus cobicistat and ritonavir boosters in human plasma
- (2019) Hélène Gouget et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Nonlinear Protein Binding: Not What You Think
- (2018) Amelia N. Deitchman et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Impact of Experimental Variables on the Protein Binding of Tigecycline in Human Plasma as Determined by Ultrafiltration
- (2018) Christoph Dorn et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults
- (2018) Michael S. Saag et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Antiviral Activity, Safety, and Pharmacokinetics of Bictegravir as 10-Day Monotherapy in HIV-1–Infected Adults
- (2017) Joel E. Gallant et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Comparative Clinical Pharmacokinetics and Pharmacodynamics of HIV-1 Integrase Strand Transfer Inhibitors
- (2016) Anthony T. Podany et al. CLINICAL PHARMACOKINETICS
- Role of Divalent Metal Ions in Atypical Nonlinear Plasma Protein Binding Behavior of Tigecycline
- (2016) Ravi Shankar Prasad Singh et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Persistent HIV-1 replication maintains the tissue reservoir during therapy
- (2016) Ramon Lorenzo-Redondo et al. NATURE
- Determination of Atypical Nonlinear Plasma–Protein-Binding Behavior of Tigecycline Using an In Vitro Microdialysis Technique
- (2014) Jatinder Kaur Mukker et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- The comparative disposition and metabolism of dolutegravir, a potent HIV-1 integrase inhibitor, in mice, rats, and monkeys
- (2014) Lee Moss et al. XENOBIOTICA
- Characterization of Binding of Raltegravir to Plasma Proteins
- (2013) Caroline Barau et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Dolutegravir Pharmacokinetics in the Genital Tract and Colorectum of HIV-Negative Men After Single and Multiple Dosing
- (2013) Benjamin N. Greener et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started